Abstract
The complexity of the tumor microenvironment, combined with the genetic heterogeneity and highly invasive nature of GB-IDHwt, makes it one of the most resistant tumors to available antineoplastic therapies. Currently, the standard treatment for GB-IDHwt involves a multimodal approach, which combines surgery for maximal tumor resection with radiotherapy and chemotherapy. However, these int…